US Bancorp’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
9,864
+9,848
| +61,550% | +$131K | ﹤0.01% | 2286 |
|
|
2025
Q1 | $163 | Sell |
16
-174
| -92% | -$1.77K | ﹤0.01% | 4083 |
|
|
2024
Q4 | $3.01K | Sell |
190
-57
| -23% | -$902 | ﹤0.01% | 3763 |
|
|
2024
Q3 | $14.3K | Sell |
247
-38
| -13% | -$2.21K | ﹤0.01% | 3228 |
|
|
2024
Q2 | $13K | Sell |
285
-110
| -28% | -$5.03K | ﹤0.01% | 3213 |
|
|
2024
Q1 | $26.1K | Buy |
395
+48
| +14% | +$3.18K | ﹤0.01% | 2979 |
|
|
2023
Q4 | $13.8K | Buy |
+347
| New | +$13.8K | ﹤0.01% | 3197 |
|
|
2023
Q3 | – | Sell |
-55
| Closed | -$2.21K | – | 4020 |
|
|
2023
Q2 | $2.21K | Hold |
55
| – | – | ﹤0.01% | 3631 |
|
|
2023
Q1 | $2.35K | Hold |
55
| – | – | ﹤0.01% | 3701 |
|
|
2022
Q4 | $2.64K | Hold |
55
| – | – | ﹤0.01% | 3684 |
|
|
2022
Q3 | $2K | Buy |
55
+14
| +34% | +$509 | ﹤0.01% | 3811 |
|
|
2022
Q2 | $1K | Hold |
41
| – | – | ﹤0.01% | 3939 |
|
|
2022
Q1 | $2K | Hold |
41
| – | – | ﹤0.01% | 3809 |
|
|
2021
Q4 | $2K | Hold |
41
| – | – | ﹤0.01% | 3864 |
|
|
2021
Q3 | $2K | Buy |
+41
| New | +$2K | ﹤0.01% | 3850 |
|